Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition
July 29, 2014 at 11:49 AM EDT
In a note released Tuesday, Citi analysts noted that AstraZeneca (NYSE: AZN) is still the most attractive acquisition target for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.